Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2

Daniel Besser, Alberto Bardelli, Svetlana Didichenko, Marcus Thelen, Paolo M. Comoglio, Carola Ponzetto, Yoshikuni Nagamine

Research output: Contribution to journalArticle

Abstract

The oncogene Tpr-Met is a constitutively active form of the hepatocyte growth factor/scatter factor (HGF/SF) receptor Met. It comprises the intracellular moiety of Met linked to the dimerization domain of the nuclear envelope protein Tpr, thus functioning as a constitutively activated Met. HGF/SF is responsible for various biological processes including angiogenesis and wound healing, in which secreted serine protease urokinase-type plasminogen activator (uPA) is implicated. The action of HGF/SF on cells is mediated by the autophosphorylation of Met on two carboxyterminal tyrosine residues, Y1349VHVNATVY1356VNV. The two tyrosine residues provide docking sites for various effector molecules, suggesting that multiple signaling pathways are activated to exert biological effects of HGF/SF. We found that Tpr-Met efficiently activates the uPA gene via a SOS/Ras/extracellular signal regulated kinase (ERK)-dependent signaling pathway. Mutation of Y1356 which abrogates GRB2, binding, reduced the induction to half of the control level, while mutation of Y1349 showed little effect on uPA induction, suggesting an important but partly replaceable role for GRB2 in Met-dependent uPA gene induction. Mutation of both Y1349VHV and Y1356VNV into optimal PI 3-kinase sites resulted in a residual induction of about one quarter of the control level, suggesting a potential role for PI 3-kinase. Dose-response analysis of the Tpr-Met showed a biphasic curve. These results suggest that the interplay among different signaling molecules on the receptor is important for full induction of the pathway leading to the activation of the uPA gene.

Original languageEnglish
Pages (from-to)705-711
Number of pages7
JournalOncogene
Volume14
Issue number6
Publication statusPublished - 1997

Fingerprint

Hepatocyte Growth Factor
Urokinase-Type Plasminogen Activator
Oncogenes
Genes
Phosphatidylinositol 3-Kinases
Mutation
Tyrosine
Proto-Oncogene Proteins c-met
Biological Phenomena
Extracellular Signal-Regulated MAP Kinases
Nuclear Envelope
Dimerization
Serine Proteases
Nuclear Proteins
Wound Healing

Keywords

  • GRB2
  • Hepatocyte growth factor
  • Plasminogen activator
  • Signal transduction
  • Tpr-Met

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Besser, D., Bardelli, A., Didichenko, S., Thelen, M., Comoglio, P. M., Ponzetto, C., & Nagamine, Y. (1997). Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene, 14(6), 705-711.

Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. / Besser, Daniel; Bardelli, Alberto; Didichenko, Svetlana; Thelen, Marcus; Comoglio, Paolo M.; Ponzetto, Carola; Nagamine, Yoshikuni.

In: Oncogene, Vol. 14, No. 6, 1997, p. 705-711.

Research output: Contribution to journalArticle

Besser, D, Bardelli, A, Didichenko, S, Thelen, M, Comoglio, PM, Ponzetto, C & Nagamine, Y 1997, 'Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2', Oncogene, vol. 14, no. 6, pp. 705-711.
Besser, Daniel ; Bardelli, Alberto ; Didichenko, Svetlana ; Thelen, Marcus ; Comoglio, Paolo M. ; Ponzetto, Carola ; Nagamine, Yoshikuni. / Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. In: Oncogene. 1997 ; Vol. 14, No. 6. pp. 705-711.
@article{af9d68c07a044d46ab7b37afbd4c8018,
title = "Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2",
abstract = "The oncogene Tpr-Met is a constitutively active form of the hepatocyte growth factor/scatter factor (HGF/SF) receptor Met. It comprises the intracellular moiety of Met linked to the dimerization domain of the nuclear envelope protein Tpr, thus functioning as a constitutively activated Met. HGF/SF is responsible for various biological processes including angiogenesis and wound healing, in which secreted serine protease urokinase-type plasminogen activator (uPA) is implicated. The action of HGF/SF on cells is mediated by the autophosphorylation of Met on two carboxyterminal tyrosine residues, Y1349VHVNATVY1356VNV. The two tyrosine residues provide docking sites for various effector molecules, suggesting that multiple signaling pathways are activated to exert biological effects of HGF/SF. We found that Tpr-Met efficiently activates the uPA gene via a SOS/Ras/extracellular signal regulated kinase (ERK)-dependent signaling pathway. Mutation of Y1356 which abrogates GRB2, binding, reduced the induction to half of the control level, while mutation of Y1349 showed little effect on uPA induction, suggesting an important but partly replaceable role for GRB2 in Met-dependent uPA gene induction. Mutation of both Y1349VHV and Y1356VNV into optimal PI 3-kinase sites resulted in a residual induction of about one quarter of the control level, suggesting a potential role for PI 3-kinase. Dose-response analysis of the Tpr-Met showed a biphasic curve. These results suggest that the interplay among different signaling molecules on the receptor is important for full induction of the pathway leading to the activation of the uPA gene.",
keywords = "GRB2, Hepatocyte growth factor, Plasminogen activator, Signal transduction, Tpr-Met",
author = "Daniel Besser and Alberto Bardelli and Svetlana Didichenko and Marcus Thelen and Comoglio, {Paolo M.} and Carola Ponzetto and Yoshikuni Nagamine",
year = "1997",
language = "English",
volume = "14",
pages = "705--711",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2

AU - Besser, Daniel

AU - Bardelli, Alberto

AU - Didichenko, Svetlana

AU - Thelen, Marcus

AU - Comoglio, Paolo M.

AU - Ponzetto, Carola

AU - Nagamine, Yoshikuni

PY - 1997

Y1 - 1997

N2 - The oncogene Tpr-Met is a constitutively active form of the hepatocyte growth factor/scatter factor (HGF/SF) receptor Met. It comprises the intracellular moiety of Met linked to the dimerization domain of the nuclear envelope protein Tpr, thus functioning as a constitutively activated Met. HGF/SF is responsible for various biological processes including angiogenesis and wound healing, in which secreted serine protease urokinase-type plasminogen activator (uPA) is implicated. The action of HGF/SF on cells is mediated by the autophosphorylation of Met on two carboxyterminal tyrosine residues, Y1349VHVNATVY1356VNV. The two tyrosine residues provide docking sites for various effector molecules, suggesting that multiple signaling pathways are activated to exert biological effects of HGF/SF. We found that Tpr-Met efficiently activates the uPA gene via a SOS/Ras/extracellular signal regulated kinase (ERK)-dependent signaling pathway. Mutation of Y1356 which abrogates GRB2, binding, reduced the induction to half of the control level, while mutation of Y1349 showed little effect on uPA induction, suggesting an important but partly replaceable role for GRB2 in Met-dependent uPA gene induction. Mutation of both Y1349VHV and Y1356VNV into optimal PI 3-kinase sites resulted in a residual induction of about one quarter of the control level, suggesting a potential role for PI 3-kinase. Dose-response analysis of the Tpr-Met showed a biphasic curve. These results suggest that the interplay among different signaling molecules on the receptor is important for full induction of the pathway leading to the activation of the uPA gene.

AB - The oncogene Tpr-Met is a constitutively active form of the hepatocyte growth factor/scatter factor (HGF/SF) receptor Met. It comprises the intracellular moiety of Met linked to the dimerization domain of the nuclear envelope protein Tpr, thus functioning as a constitutively activated Met. HGF/SF is responsible for various biological processes including angiogenesis and wound healing, in which secreted serine protease urokinase-type plasminogen activator (uPA) is implicated. The action of HGF/SF on cells is mediated by the autophosphorylation of Met on two carboxyterminal tyrosine residues, Y1349VHVNATVY1356VNV. The two tyrosine residues provide docking sites for various effector molecules, suggesting that multiple signaling pathways are activated to exert biological effects of HGF/SF. We found that Tpr-Met efficiently activates the uPA gene via a SOS/Ras/extracellular signal regulated kinase (ERK)-dependent signaling pathway. Mutation of Y1356 which abrogates GRB2, binding, reduced the induction to half of the control level, while mutation of Y1349 showed little effect on uPA induction, suggesting an important but partly replaceable role for GRB2 in Met-dependent uPA gene induction. Mutation of both Y1349VHV and Y1356VNV into optimal PI 3-kinase sites resulted in a residual induction of about one quarter of the control level, suggesting a potential role for PI 3-kinase. Dose-response analysis of the Tpr-Met showed a biphasic curve. These results suggest that the interplay among different signaling molecules on the receptor is important for full induction of the pathway leading to the activation of the uPA gene.

KW - GRB2

KW - Hepatocyte growth factor

KW - Plasminogen activator

KW - Signal transduction

KW - Tpr-Met

UR - http://www.scopus.com/inward/record.url?scp=0031045203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031045203&partnerID=8YFLogxK

M3 - Article

C2 - 9038378

AN - SCOPUS:0031045203

VL - 14

SP - 705

EP - 711

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 6

ER -